Crossmark

Biofunctionalization of silk fibroin scaffolds with enamel matrix protein and injectable platelet rich fibrin for soft tissue augmentation: an in-ovo study

Crossref DOI link: https://doi.org/10.1186/s40729-025-00601-1

Published Online: 2025-02-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Heimes, Diana

Wiesmann-Imilowski, Nadine

Heidebrecht, Timpe

Blatt, Sebastian

Pabst, Andreas

Becker, Philipp

Fuest, Sandra

Brieger, Jürgen

Smeets, Ralf

Kämmerer, Peer W.
Funding

Funding for this research was provided by:

Universitätsmedizin der Johannes Gutenberg-Universität Mainz
License Information

Text and Data Mining valid from 2025-02-20

Version of Record valid from 2025-02-20
More Information

Article History

Received: 23 December 2024

Accepted: 12 February 2025

First Online: 20 February 2025

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (“Ärztekammer Rheinland Pfalz, reference number: “2019–14705_1”) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all subjects involved in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below